AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 282 min read$RDNT

RadNet to Buy ONRAD in $350M Deal, Expanding Hospital Radiology Services

RadNet (RDNT) to acquire ONRAD for $350M, expanding hospital radiology services. ONRAD has 30%+ EBITDA margins, $60M-$65M adjusted EBITDA. RadNet plans to integrate ONRAD's network with its DeepHealth AI platform, aiming for operational synergies and cross-selling opportunities. The deal is expected to close in 2024.

Original reporting
finance.yahoo.com
Published Oct 28, 2026, 12:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 12:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
RadNet to Buy ONRAD in $350M Deal, Expanding Hospital Radiology Services — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$RDNTNeutralHigh
01

Why it matters

The deal creates a larger, AI‑enabled radiology platform, potentially improving margins and cross‑sell opportunities while modestly increasing debt.

02

Market read

The acquisition is a material corporate action for RadNet, likely influencing its stock price and the broader radiology services sector.

03

What to watch

Potential competition from larger health systems and the speed of AI platform rollout could affect realized benefits.

Relevance 9/10Novelty 9/10Timing: today

Background

RadNet, a NASDAQ-listed outpatient diagnostic imaging company, is expanding its service offering by acquiring ONRAD, a teleradiology provider.

Company-level read

Ticker impact

$RDNTNeutralMedium confidence
Context

RadNet announced a $350M acquisition of ONRAD, expanding its hospital radiology services and AI platform integration.

Expected impact

potential modest upside as investors price in growth and AI synergies, tempered by higher leverage.

Evidence & confidence

Deal size and strategic fit are material, yet integration risk and added debt could limit upside.

Market effects

Sector

Consolidation in outpatient imaging and increased AI adoption across radiology services.

Regional

Strengthens RadNet's presence in U.S. hospital markets, especially in the 11 and 21 states covered by the two firms.

Global

Limited to U.S. healthcare imaging sector; minimal direct global impact.

Counterpoint

What could challenge this read

The added leverage and integration complexity may outweigh the expected synergies, pressuring the stock.

Key entities

  • company
    RadNet, Inc.

    NASDAQ-listed outpatient diagnostic imaging provider.

  • company
    ONRAD

    Teleradiology operator focused on hospital radiology services.

Read at source← All news

StoryRadNet to acquire ONRAD, adding hospital radiology services

Also covered by

3 outlets

Related articles

OCT 27
$RDNTHighAI 8/10

Truist reiterates Buy on RadNet stock after ONRAD acquisition

Truist Securities reiterated a Buy rating and $94 price target on RadNet (RDNT) after its $700M acquisition of ONRAD. The deal includes cash, shares, and an earnout. RadNet's stock trades at $73.77, with analysts citing growth potential. The company reported strong Q2 2026 results, raising guidance and prompting price target increases from multiple analysts.

investing.com2 min
OCT 27
HighAI 9/10

RadNet acquires ONRAD in $355m deal to broaden radiology provision

RadNet agreed to acquire ONRAD for $355m ($350m cash, $5m shares) with a potential $210m earnout. The deal, expected to close in early 2027, aims to expand RadNet's radiology services and address staffing shortages. RadNet plans to integrate ONRAD's teleradiology and staffing services with its AI-based solutions to improve efficiency and patient care. Jefferies analysts called it a 'sound transaction.'

medicaldevice-network.com2 min
SEP 16
$RDNTHighAI 8/10

Testing & Diagnostics Services Stocks Q2 Results: Benchmarking Guardant Health (NASDAQ:GH)

Guardant Health, RadNet (NASDAQ:RDNT), Labcorp (NYSE:LH), NeoGenomics (NASDAQ:NEO), and Quest (NYSE:DGX) reported Q2 results. RadNet saw 25% revenue growth, beating estimates. Labcorp's revenue grew 5.8%, meeting expectations but underperforming peers. NeoGenomics and Quest both beat estimates with 11.2% and 10.2% revenue growth, respectively. Stocks have risen since reporting.

yahoo.com3 min
SEP 4
$RDNTMed

RadNet (RDNT) Posts Record Revenue But Profit Growth Lags

RadNet (RDNT) reported Q2 2026 revenue of $622.7M, up 25% YoY, and raised full-year guidance. Profit growth lagged, with net income falling to $7.5M from $14.5M YoY. Digital Health revenue grew 56.5%, but its EBITDA dropped 27.2%. Hedge fund ownership declined, while short interest remains high at 14.56%.

insidermonkey.com3 min
AUG 11
$ABXMed

Barrick Profit Soars, Nvidia Eyes $500B AI Push, M&A Accelerates

The article reports multiple US corporate updates. Barrick Mining said Q2 profit rose 50% to $1.22B, with revenue up 44% to $5.29B, and agreed with Newmont on a $1.95B cash top-up to expand Nevada Gold Mines. Nvidia is working on a $500B AI financing venture; Intel announced a $15B stock offering. It also covers results for Axsome (revenue +46%), Monday.com, RadNet, NESR, and Camtek.

hdfcsky.com7 min